PARIS, France—Even after following patients for another 12 months, MITRA-FR investigators have the same answer they did 1 year ago: percutaneous repair of functional mitral regurgitation (MR) using ...
PARIS — An additional year of follow-up in the MITRA-FR trial confirm no added benefit of percutaneous repair of functional mitral regurgitation (MR) with the MitraClip (Abbott) compared with optimal ...
PARIS — In patients with HF with reduced ejection fraction and secondary mitral valve regurgitation, percutaneous mitral valve repair with MitraClip plus medical therapy offered no advantage over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback